Hugh Calkins, MD, FHRS, CCDS, was named the president of the Heart Rhythm Society (HRS) during the 34th Annual Scientific Sessions, held in Denver last week.  Announced during the Presidents’ Reception on Friday, May 10th, Dr. Calkins now serves as the 35th president of HRS, making Anne M. Gillis, MD, FHRS, the immediate past president. Dr. Calkins is currently a Nicholas J. Fortuin Professor of Cardiology and Professor of Medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland.  

Seven percent of patients implanted with subcutaneous implantable cardioverter-defibrillators (S-ICDs) experienced inappropriate shocks, according to an analysis of registry data presented May 9 at the Heart Rhythm Society (HRS) scientific sessions in Denver.

The Watchman wait may be over. An analysis of long-term data found the Watchman left atrial appendage closure device to be superior to warfarin for primary efficacy and mortality.

Patients with paroxysmal atrial fibrillation (AF) were less likely to receive guideline recommended anticoagulation therapy compared with persistent AF patients. The analysis presented May 8 at the Heart Rhythm Society scientific sessions in Denver included registry data on more than 62,000 patients.

Anne M. Gillis, MD, president of the Heart Rhythm Society and a professor at the University of Calgary, will co-chair a joint session on clinical registries on May 9 at Heart Rhythm 2013 in Denver. In a Q&A with Cardiovascular Business, she discussed the evolution of joint sessions and other program details.

ASE members discuss recent changes to contrast enhanced stress echo.

Heart Rhythm Society (HRS) will offer new sessions as well as topics that were well received at previous meetings for its 2013 scientific sessions scheduled May 8-11 in Denver.

The American Society of Echocardiography (ASE) and GE Healthcare have teamed to provide a cardiovascular ultrasound training event for healthcare providers caring for underserved populations in rural northwest India.